BG Medicine, Inc. (BGMD)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 26, 2025, 8:00 PM EDT
BG Medicine Revenue
In the year 2015, BG Medicine had annual revenue of $1.57M, down -43.81%. BG Medicine had revenue of $290.00K in the quarter ending December 31, 2015, a decrease of -47.65%.
Revenue
1.57M
Revenue Growth
-43.81%
P/S Ratio
0.00
Revenue / Employee
313.20K
Employees
5
Market Cap
1.14K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2015 | 1.57M | -1.22M | -43.81% |
| Dec 31, 2014 | 2.79M | -1.29M | -31.57% |
| Dec 31, 2013 | 4.07M | 1.26M | 44.69% |
| Dec 31, 2012 | 2.82M | 1.18M | 72.28% |
| Dec 31, 2011 | 1.63M | 815.00K | 99.51% |
| Dec 31, 2010 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| American Oncology Network | 1.76B |
| Veradigm | 588.02M |
| Jushi Holdings | 256.36M |
| Glass House Brands | 221.55M |
| Elite Pharmaceuticals | 105.45M |
| Silence Therapeutics | 27.17M |
| Nuo Therapeutics | 1.95M |
| Northwest Biotherapeutics | 1.09M |